Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Toonaangevende leiders

HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van bedrijfsleiders 
Overzicht 
Paul Jai Sekhri is an American businessperson who founded Cerimon Pharmaceuticals, Inc. and who has been the head of 13 different companies. Presently, he is Chairman of Compugen Ltd., Chairman for Pharming Group NV, Chairman at The Knights, Chairman at Longboard Pharmaceuticals, Inc., President, Chief Executive Officer & Director at vTv Therapeutics, Inc., Venture Partner at Medicxi Ventures (Jersey) Ltd., Advisor at Epidarex Capital Partners LLC, Advisor at Trialspark, Inc. and Chairman at Pharming NV.

He is also Member of Ontario Institute for Cancer Research and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 14 other companies.

He previously occupied the position of Chairman for moksha8 Pharmaceuticals, Inc., Chairman for Topas Therapeutics GmbH, President & Chief Executive Officer for Cerimon Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Lycera Corp., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., Venture Partner at MPM Capital Inc, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Member-Patrons Council at The Carnegie Hall Society, Inc., Chairman at Petra Pharma Corp., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG, Senior Vice President-Integrated Care at Sanofi SA and Operating Partner at Highline Therapeutics, Inc.

Mr. Sekhri received an undergraduate degree from the University of Maryland and a graduate degree from the University of Maryland School of Medicine.


Posities en verantwoordelijkheden van Paul Jai Sekhri 
NaamTitel Van
Veeva Systems Inc.
(Geavanceerde medische apparatuur & technologie)
Board of Director 2014
Ipsen S.A.
(Farmaceutische producten)
Independent Director 2018
Pharming Group N.V.
(Farmaceutische producten)
Chairman 2016
Longboard Pharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2020
Compugen Ltd.
(Biotechnologie & Medisch Onderzoek)
Chairman 2017
vTv Therapeutics Inc.
(Biotechnologie & Medisch Onderzoek)
President, Chief Executive Officer & Director 2022
Axcella Health Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2022
The Knights Chairman 2017
The BioExec Institute, Inc. Director -
LikeMinds, Inc. (Massachusetts) Director -
Spring Discovery, Inc. Director 2021
eGenesis, Inc. Director 2022
Young Concert Artists, Inc. Director -
Orchestra of St. Luke's Director 2018
The Caramoor Center for Music & the Arts, Inc. Director -
Cancer Research Institute Director -
Pharming NV Chairman -
Metropolitan Opera Association, Inc. Director 2018
Cita NeuroPharmaceuticals, Inc. Director -
Global Alliance for TB Drug Development Director -
Tarrant Capital IP LLC Managing Director & Operating Partner -
Ontario Institute for Cancer Research Member -
Epidarex Capital Partners LLC Advisor -
Medicxi Ventures (Jersey) Ltd. Venture Partner 2020
Trialspark, Inc. Advisor -


Belangnemingen van Paul Jai Sekhri 
NaamAandelen%Totale waarde
Veeva Systems Inc. (VEEV)
(Geavanceerde medische apparatuur & technologie)
18 7260,013%3 022 002 USD
Pharming Group N.V. (PHARM)
(Farmaceutische producten)
486 0370,075%562 296 USD
BiomX Inc. (PHGE)
(Biotechnologie & Medisch Onderzoek)
12 5000,042%2 338 USD
Longboard Pharmaceuticals, Inc. (LBPH)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


Paul Jai SekhriPersoonlijk netwerk 
Meest gelezen nieuws 
26/01Musk zegt dat Chinese rivalen 'het hardst en het slimst werken'
MR
26/01LVMH's Arnault wimpelt opvolgingsvraag af
MR
27/01Wood's ARK Innovation Fund op weg naar de beste maand ooit door een opleving van gehavende aandelen
MR
27/01Bill Ackman zegt dat Hindenburgs rapport over Adani Group 'zeer geloofwaardig' is
MR
19/01JPMorgan CEO Dimon ziet rente boven 5% komen - CNBC
MR
19/01Ontslagen GM-werknemers in India klagen bedrijf en CEO Barra aan voor onbetaalde compensatie
MR
20/01Musk wordt verwacht te getuigen als proces over Tesla-tweet wordt hervat
MR
18/01Takeaway CEO Groen: verkoopproces voor Grubhub 'moeilijk' gezien huidige M&A-markt
MR
24/01Rupert Murdoch schrapt voorstel om Fox en News Corp te combineren
MR
17/01Disney zegt dat investeerder Peltz 'geen ervaring heeft' om zijn bedrijf te begrijpen
MR
Meer nieuws


© 2023 People and Ownership :   
Paul Jai Sekhri Verbindingen